| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 206.63M | 216.92M | 221.02M | 207.35M | 178.68M |
| Gross Profit | 152.79M | 159.60M | 158.39M | 148.12M | 131.84M |
| EBITDA | 60.13M | 62.64M | 65.03M | 60.51M | 44.70M |
| Net Income | 8.68M | 10.46M | 8.70M | 7.31M | 6.91M |
Balance Sheet | |||||
| Total Assets | 725.26M | 707.07M | 734.12M | 716.03M | 613.44M |
| Cash, Cash Equivalents and Short-Term Investments | 76.06M | 49.73M | 52.73M | 44.22M | 43.30M |
| Total Debt | 7.48M | 380.82M | 380.39M | 380.47M | 178.23M |
| Total Liabilities | 620.39M | 615.48M | 619.11M | 585.73M | 272.20M |
| Stockholders Equity | 79.27M | 64.05M | 82.02M | 79.00M | 179.39M |
Cash Flow | |||||
| Free Cash Flow | 50.09M | 55.98M | 54.82M | 44.11M | 33.14M |
| Operating Cash Flow | 53.00M | 56.51M | 55.60M | 44.35M | 41.35M |
| Investing Cash Flow | -2.91M | -386.00K | -785.00K | -245.00K | -8.20M |
| Financing Cash Flow | -23.80M | -59.15M | -46.38M | -36.62M | -26.56M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | $313.89M | ― | 15.38% | ― | -5.47% | 13.42% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | $363.84M | 2.96 | 22.00% | 2.39% | -12.10% | ― | |
52 Neutral | $1.00B | -3.02 | 1.62% | 3.51% | -1.34% | -73.59% | |
51 Neutral | $137.70M | -5.72 | -18.73% | ― | -13.14% | 57.98% | |
49 Neutral | $83.23M | -50.67 | 6.60% | ― | 30.04% | -53.50% | |
46 Neutral | $390.61M | -1.34 | -63.90% | ― | -5.64% | -577.74% |
On February 9, 2026, European Wax Center entered into a definitive merger agreement under which an affiliate of General Atlantic, already a 42% shareholder, will acquire all remaining Class A shares it does not own and take the U.S. waxing franchisor private. Unaffiliated holders of Class A common stock will receive $5.80 per share in cash, implying an equity value of about $330 million and representing a 45% premium to the February 9 closing price and a 51% premium to the 90-day volume-weighted average.
The deal, unanimously recommended by an independent special committee and approved by the board, includes cash-out treatment for equity awards, appraisal rights for dissenting holders and customary no-shop, termination fee and reverse termination fee provisions. Closing, targeted for mid-2026, remains subject to approval by a majority of disinterested shareholders, regulatory clearances under U.S. antitrust law and other conditions, after which the stock will be delisted from Nasdaq and the company will operate as a privately held, General Atlantic–backed business.
The most recent analyst rating on (EWCZ) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on European Wax Center stock, see the EWCZ Stock Forecast page.